Munich Diabetes Family Study
- Conditions
- TYP-2-DIABETESE11.9
- Registration Number
- DRKS00004229
- Lead Sponsor
- Else Kröner-fresenius-Zentrum für ErnährungsmedizinKlinikum rechts der Isar der TU MünchenUptown München Campus D
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting stopped after recruiting started
- Sex
- All
- Target Recruitment
- 24
type 2 diabetes families: at least two generations (parents, children); at least one parent with T2D; at least three participants per family (trio”) with one disease-free index subject
- Caucasian origin
- no BMI restriction
- written informed consent
- severe diseases, e.g. cancer, COPD, severe heart disease, progressive renal failure, severe psychiatric or neurological diseases
- type 1 diabetes, MODY or other rare types of diabetes
- drug or alcohol abuse
- continuous treatment with drugs influencing glucose tolerance, insulin sensitivity and/or insulin secretion
- continuous treatment with oral anticoagulants or antithrombotics (except ASS 100)
- gastrointestinal diseases impairing glucose absorption during oGTT
- insufficient language skills
- lack of written informed consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Characterization (geno-/phenotyping) of a cohort of families with type 2 diabetes.
- Secondary Outcome Measures
Name Time Method - identification of potential new diagnostic biomarkers in a T2D risk cohort<br>- validation and cross-validation of newly detected biomarker signatures <br>- function of diabetes-related single nucleotid polymorphisms <br>- development and validation of specific dietary recommendations for disease prevention